Nervous System Active Pharmaceutical Ingredients Market Size & Share, by Product (Cytokines, Vaccines, Fusion Proteins, Therapeutic Enzymes); Expression System (Mammalian, Microbial Yeast); Application (Diabetes, CVDs, Oncology, Neurological Disorder) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

Request Free Sample Copy

Report ID: 4212
Published Date: May 01, 2023
Report Format: PDF, PPT

Buy Now

Companies Dominating the Nervous System Active Pharmaceutical Ingredients Landscape

Pfizer, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Boehringer Ingelheim International GmbH
Bristol Myers Squibb Company
Shenzhen Hepalink Pharmaceutical Co. Ltd.
GSK plc
F. Hoffmann-La Roche Ltd
Cipla Inc.
Eli Lilly and Company
Novartis AG,
Teva Pharmaceutical Industries Ltd.

Browse Key Market Insights with Data Illustration:

Nervous System Active Pharmaceutical Ingredients Market Forecasts 2035

In the News

Boehringer Ingelheim International GmbH to partner with Carthronix, a biopharmaceutical company to develop therapies based on small molecules to cure diseases associated with elderly people. The research & development are further associated with small molecule therapeutics in canine oncology.
F. Hoffmann-La Roche Ltd to acquire acceptance from FDA for its Biologics License Applications. The application is associated with untreated diffuse large B-cell lymphoma.

Frequently Asked Questions (FAQ)

The growing presence of chronic diseases across the globe and the growing geriatric population are the major factors driving the growth of the market.

The market size of the Nervous System Active Pharmaceutical Ingredients Market is anticipated to attain a CAGR of 5% over the forecast period, i.e., 2023-2035.

The major players in the market are Boehringer Ingelheim International GmbH, Bristol Myers Squibb Company, Shenzhen Hepalink Pharmaceutical Co. Ltd., GSK plc, F. Hoffmann-La Roche Ltd, Cipla Inc., Eli Lilly and Company, Novartis AG, Teva Pharmaceutical Industries Ltd.

The CVDs segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Companies Dominating the Nervous System Active Pharmaceutical Ingredients Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the Nervous System Active Pharmaceutical Ingredients Market?

What would be the CAGR of the Nervous System Active Pharmaceutical Ingredients Market over the forecast period?

Who are the major players dominating the Nervous System Active Pharmaceutical Ingredients Market?

Which segment captures the largest market size in the application segment in the Nervous System Active Pharmaceutical Ingredients Market?